Itcalms Plus 5 Tablet is a combination medication containing Clonazepam 0.5 mg and Escitalopram Oxalate 5 mg, indicated for the management of anxiety disorders, panic attacks, and depression with concurrent anxiety symptoms. Clonazepam, a benzodiazepine, exerts its therapeutic effect by enhancing the activity of gamma-aminobutyric acid (GABA), producing anxiolytic, anticonvulsant, and muscle relaxant properties. Escitalopram Oxalate, a selective serotonin reuptake inhibitor (SSRI), increases serotonin levels in the brain, thereby improving mood and reducing anxiety. The combined formulation provides synergistic benefits by addressing both acute anxiety symptoms and underlying depressive disorders. Itcalms Plus 5 is prescribed under medical supervision, with dosage tailored to individual patient needs. Common side effects may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with a history of substance abuse, hepatic or renal impairment, and those taking other central nervous system depressants. Abrupt discontinuation should be avoided to prevent withdrawal symptoms. Regular monitoring by healthcare professionals is essential to assess therapeutic response and minimize adverse effects. Itcalms Plus 5 should be used as part of a comprehensive treatment plan including psychotherapy and lifestyle modifications.